- Advertisement - <\/p>\n
Kvantify, a Copenhagen-based quantum software startup, has successfully closed a 10 million seed round. This funding will enable the startup to strengthen its position as a global leader in quantum computing, focusing initially on life sciences applications. The round is led by Danish VC Dreamcraft, alongside biotech investor Lundbeckfonden BioCapital and the private investment company 2degrees, with participation from Redstone VC, 2xN, and EIFO. Kvantify plans to use the investment to accelerate the development of quantum solutions for drug discovery and chemical simulation, aiming to address complex problems and expand applicability across various industries. This strategic funding will enhance Kvantifys innovative capabilities, ensuring a significant impact on the life sciences sector and beyond. <\/p>\n
Kvantify is dedicated to harnessing the power of quantum computing to solve complex scientific and industrial challenges. With a strong emphasis on life sciences, Kvantify develops advanced quantum algorithms and high-performance computing solutions aimed at revolutionizing drug discovery and chemical simulation. Their mission is to make quantum technology accessible and valuable to businesses worldwide, driving innovation and efficiency in various sectors. Leveraging an interdisciplinary team and cutting-edge technology, Kvantify is positioned at the forefront of the quantum computing revolution. <\/p>\n
The seed round is notable not only for its substantial size but also for the strategic match of the new investors to Kvantifys mission. It is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and the private investment company 2degrees. Other notable investors include international sector-focused tech investor Redstone VC, Danish lead quantum VC 2xN as well as EIFO. <\/p>\n
Lundbeckfonden BioCapital is a large Danish investor focused on local life science companies, supporting the translation and commercialization of ground-breaking science. This is Lundbeckfonden BioCapitals first investment outside the therapeutics space. <\/p>\n
With our investment in Kvantify, we are broadening our footprint in and commitment to further strengthening the Danish life science ecosystem. Quantum computing can deliver accuracy and derisking to the early stages of drug development to a level not possible with classical computers, thereby enabling faster speed to market. We are therefore excited about this opportunity and look forward to working with the Kvantify team to bridge quantum computing and drug development to the future benefit of patients, said Jacob Falck Hansen, Partner at Lundbeckfonden BioCapital. <\/p>\n
Danish VC Dreamcraft invests in tech-driven companies, from pre-seed to series A, and has a proven track record with B2B SaaS software. <\/p>\n
Were thrilled to partner with the team at Kvantify as they take a significant step forward in their mission to fulfill the promise of industrial applications of quantum computers. The potential of quantum chemical computational drug discovery is massive and represents a truly exciting beachhead market. We cannot wait to see how Kvantify will help solve todays seemingly impossible problems and serve as a crucial tool in designing the solutions of the future. says Carsten Salling, General Partner at Dreamcraft. <\/p>\n
Redstone QAI Quantum Fund is a highly specialized venture capital fund that focuses on investing in groundbreaking technologies within the quantum technologies sector. <\/p>\n
Kvantifys focus on applying quantum computing to life sciences and further industrial use cases across various sectors aligns with our strategic vision of advancing practical and impactful quantum solutions. With their interdisciplinary team, in-depth knowledge of quantum technology, and innovative approach to enhancing computational efficiency, Kvantify is perfectly placed to bring tremendous value to commercial markets, says Marco Stutz, Partner at Redstone. <\/p>\n
In light of their successful product launch for a groundbreaking drug discovery tool, Hans Henrik Knudsen, CEO of Kvantify, comments: <\/p>\n
On behalf of the founding team, we are incredibly excited about the completion of our 10 million seed round, which marks a significant milestone for Kvantify. This funding not only validates our vision of leveraging quantum computing to revolutionize the life sciences industry but also provides us with the resources and strategic partnerships needed to accelerate our development and growth. With the support of new and existing investors, we are well-positioned to continue to bring groundbreaking solutions to market. <\/p>\n
Click to read more funding news. <\/p>\n
- Advertisement - <\/p>\n
<\/p>\n
Read the rest here: - Advertisement - Kvantify, a Copenhagen-based quantum software startup, has successfully closed a 10 million seed round. This funding will enable the startup to strengthen its position as a global leader in quantum computing, focusing initially on life sciences applications. Continue reading
\nDanish startup secures 10M seed to advance quantum computing in life sciences - ArcticStartup<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"